Bladder Cancer Therapeutics

Bladder Cancer Therapeutics

Bladder Cancer Therapeutics market worldwide is projected to grow by US$89.9 Million, driven by a compounded growth of 4.8%. Transitional Cell Bladder Cancer, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$111.4 Million by the year 2025, Transitional Cell Bladder Cancer will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$3.2 Million to the region's size and clout in the next 5 to 6 years. Over US$2.6 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Transitional Cell Bladder Cancer will reach a market size of US$5.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.7% over the next couple of years and add approximately US$26.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, AstraZeneca plc; Bristol-Myers Squibb Company; Celgene Corporation; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Novartis International AG; Pfizer, Inc.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Bladder Cancer Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Bladder Cancer Therapeutics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
TABLE 2: Bladder Cancer Therapeutics Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
TABLE 3: Bladder Cancer Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Transitional Cell Bladder Cancer (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
TABLE 5: Transitional Cell Bladder Cancer (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
TABLE 6: Transitional Cell Bladder Cancer (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Non Muscle Invasive/Superficial Bladder Cancer (Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
TABLE 8: Non Muscle Invasive/Superficial Bladder Cancer (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
TABLE 9: Non Muscle Invasive/Superficial Bladder Cancer (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: Invasive Bladder Cancer (Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
TABLE 11: Invasive Bladder Cancer (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
TABLE 12: Invasive Bladder Cancer (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Squamous Cell Bladder Cancer (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
TABLE 14: Squamous Cell Bladder Cancer (Type) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
TABLE 15: Squamous Cell Bladder Cancer (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Adenocarcinoma of the Bladder (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
TABLE 17: Adenocarcinoma of the Bladder (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
TABLE 18: Adenocarcinoma of the Bladder (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 19: Rare Bladder Cancers (Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
TABLE 20: Rare Bladder Cancers (Type) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017
TABLE 21: Rare Bladder Cancers (Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
TABLE 22: Surgery (Treatment) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025
TABLE 23: Surgery (Treatment) Global Historic Demand in US$ Thousand by Region/Country: 2009 to 2017
TABLE 24: Surgery (Treatment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 25: Chemotherapy (Treatment) World Market by Region/Country in US$ Thousand: 2018 to 2025
TABLE 26: Chemotherapy (Treatment) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
TABLE 27: Chemotherapy (Treatment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 28: Immunotherapy (Treatment) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
TABLE 29: Immunotherapy (Treatment) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
TABLE 30: Immunotherapy (Treatment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 31: Radiation Therapy (Treatment) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
TABLE 32: Radiation Therapy (Treatment) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
TABLE 33: Radiation Therapy (Treatment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 34: Intravesical Therapy (Treatment) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
TABLE 35: Intravesical Therapy (Treatment) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
TABLE 36: Intravesical Therapy (Treatment) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Bladder Cancer Therapeutics Market Share (in %) by Company: 2019 & 2025
TABLE 37: United States Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025
TABLE 38: Bladder Cancer Therapeutics Market in the United States by Type: A Historic Review in US$ Thousand for 2009-2017
TABLE 39: United States Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 40: United States Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
TABLE 41: Bladder Cancer Therapeutics Market in the United States by Treatment: A Historic Review in US$ Thousand for 2009-2017
TABLE 42: United States Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
CANADA
TABLE 43: Canadian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
TABLE 44: Canadian Bladder Cancer Therapeutics Historic Market Review by Type in US$ Thousand: 2009-2017
TABLE 45: Bladder Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
TABLE 46: Canadian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
TABLE 47: Canadian Bladder Cancer Therapeutics Historic Market Review by Treatment in US$ Thousand: 2009-2017
TABLE 48: Bladder Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
JAPAN
TABLE 49: Japanese Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
TABLE 50: Bladder Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
TABLE 51: Japanese Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 52: Japanese Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
TABLE 53: Bladder Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
TABLE 54: Japanese Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
CHINA
TABLE 55: Chinese Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025
TABLE 56: Bladder Cancer Therapeutics Historic Market Analysis in China in US$ Thousand by Type: 2009-2017
TABLE 57: Chinese Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 58: Chinese Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
TABLE 59: Bladder Cancer Therapeutics Historic Market Analysis in China in US$ Thousand by Treatment: 2009-2017
TABLE 60: Chinese Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Bladder Cancer Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 61: European Bladder Cancer Therapeutics Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
TABLE 62: Bladder Cancer Therapeutics Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
TABLE 63: European Bladder Cancer Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 64: European Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025
TABLE 65: Bladder Cancer Therapeutics Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017
TABLE 66: European Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 67: European Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
TABLE 68: Bladder Cancer Therapeutics Market in Europe in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
TABLE 69: European Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
FRANCE
TABLE 70: Bladder Cancer Therapeutics Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 71: French Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Type: 2009-2017
TABLE 72: French Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 73: Bladder Cancer Therapeutics Market in France by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 74: French Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Treatment: 2009-2017
TABLE 75: French Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
GERMANY
TABLE 76: Bladder Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
TABLE 77: German Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
TABLE 78: German Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 79: Bladder Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 80: German Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 81: German Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
ITALY
TABLE 82: Italian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025
TABLE 83: Bladder Cancer Therapeutics Historic Market Analysis in Italy in US$ Thousand by Type: 2009-2017
TABLE 84: Italian Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 85: Italian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
TABLE 86: Bladder Cancer Therapeutics Historic Market Analysis in Italy in US$ Thousand by Treatment: 2009-2017
TABLE 87: Italian Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
TABLE 88: United Kingdom Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
TABLE 89: Bladder Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
TABLE 90: United Kingdom Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 91: United Kingdom Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
TABLE 92: Bladder Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
TABLE 93: United Kingdom Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
SPAIN
TABLE 94: Spanish Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
TABLE 95: Spanish Bladder Cancer Therapeutics Historic Market Review by Type in US$ Thousand: 2009-2017
TABLE 96: Bladder Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
TABLE 97: Spanish Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
TABLE 98: Spanish Bladder Cancer Therapeutics Historic Market Review by Treatment in US$ Thousand: 2009-2017
TABLE 99: Bladder Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
RUSSIA
TABLE 100: Russian Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025
TABLE 101: Bladder Cancer Therapeutics Market in Russia by Type: A Historic Review in US$ Thousand for 2009-2017
TABLE 102: Russian Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 103: Russian Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
TABLE 104: Bladder Cancer Therapeutics Market in Russia by Treatment: A Historic Review in US$ Thousand for 2009-2017
TABLE 105: Russian Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 106: Rest of Europe Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025
TABLE 107: Bladder Cancer Therapeutics Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017
TABLE 108: Rest of Europe Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 109: Rest of Europe Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
TABLE 110: Bladder Cancer Therapeutics Market in Rest of Europe in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
TABLE 111: Rest of Europe Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 112: Asia-Pacific Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
TABLE 113: Bladder Cancer Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017
TABLE 114: Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
TABLE 115: Bladder Cancer Therapeutics Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 116: Asia-Pacific Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Type: 2009-2017
TABLE 117: Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 118: Bladder Cancer Therapeutics Market in Asia-Pacific by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 119: Asia-Pacific Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Treatment: 2009-2017
TABLE 120: Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
AUSTRALIA
TABLE 121: Bladder Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
TABLE 122: Australian Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
TABLE 123: Australian Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 124: Bladder Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 125: Australian Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 126: Australian Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
INDIA
TABLE 127: Indian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
TABLE 128: Indian Bladder Cancer Therapeutics Historic Market Review by Type in US$ Thousand: 2009-2017
TABLE 129: Bladder Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
TABLE 130: Indian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
TABLE 131: Indian Bladder Cancer Therapeutics Historic Market Review by Treatment in US$ Thousand: 2009-2017
TABLE 132: Bladder Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
SOUTH KOREA
TABLE 133: Bladder Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
TABLE 134: South Korean Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
TABLE 135: Bladder Cancer Therapeutics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
TABLE 136: Bladder Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 137: South Korean Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 138: Bladder Cancer Therapeutics Market Share Distribution in South Korea by Treatment: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
TABLE 139: Rest of Asia-Pacific Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
TABLE 140: Bladder Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
TABLE 141: Rest of Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 142: Rest of Asia-Pacific Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
TABLE 143: Bladder Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
TABLE 144: Rest of Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
LATIN AMERICA
TABLE 145: Latin American Bladder Cancer Therapeutics Market Trends by Region/Country in US$ Thousand: 2018-2025
TABLE 146: Bladder Cancer Therapeutics Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017
TABLE 147: Latin American Bladder Cancer Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
TABLE 148: Latin American Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025
TABLE 149: Bladder Cancer Therapeutics Historic Market Analysis in Latin America in US$ Thousand by Type: 2009-2017
TABLE 150: Latin American Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 151: Latin American Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
TABLE 152: Bladder Cancer Therapeutics Historic Market Analysis in Latin America in US$ Thousand by Treatment: 2009-2017
TABLE 153: Latin American Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
TABLE 154: Argentinean Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025
TABLE 155: Bladder Cancer Therapeutics Market in Argentina in US$ Thousand by Type: A Historic Review for the Period 2009-2017
TABLE 156: Argentinean Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 157: Argentinean Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
TABLE 158: Bladder Cancer Therapeutics Market in Argentina in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
TABLE 159: Argentinean Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
BRAZIL
TABLE 160: Bladder Cancer Therapeutics Market in Brazil by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 161: Brazilian Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Type: 2009-2017
TABLE 162: Brazilian Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 163: Bladder Cancer Therapeutics Market in Brazil by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 164: Brazilian Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Treatment: 2009-2017
TABLE 165: Brazilian Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
MEXICO
TABLE 166: Bladder Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
TABLE 167: Mexican Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
TABLE 168: Mexican Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 169: Bladder Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 170: Mexican Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 171: Mexican Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
TABLE 172: Rest of Latin America Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025
TABLE 173: Bladder Cancer Therapeutics Market in Rest of Latin America by Type: A Historic Review in US$ Thousand for 2009-2017
TABLE 174: Rest of Latin America Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 175: Rest of Latin America Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
TABLE 176: Bladder Cancer Therapeutics Market in Rest of Latin America by Treatment: A Historic Review in US$ Thousand for 2009-2017
TABLE 177: Rest of Latin America Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
MIDDLE EAST
TABLE 178: The Middle East Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
TABLE 179: Bladder Cancer Therapeutics Market in the Middle East by Region/Country in US$ Thousand: 2009-2017
TABLE 180: The Middle East Bladder Cancer Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
TABLE 181: The Middle East Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
TABLE 182: The Middle East Bladder Cancer Therapeutics Historic Market by Type in US$ Thousand: 2009-2017
TABLE 183: Bladder Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
TABLE 184: The Middle East Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
TABLE 185: The Middle East Bladder Cancer Therapeutics Historic Market by Treatment in US$ Thousand: 2009-2017
TABLE 186: Bladder Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
IRAN
TABLE 187: Iranian Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
TABLE 188: Bladder Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
TABLE 189: Iranian Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
TABLE 190: Iranian Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
TABLE 191: Bladder Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
TABLE 192: Iranian Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
ISRAEL
TABLE 193: Israeli Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025
TABLE 194: Bladder Cancer Therapeutics Market in Israel in US$ Thousand by Type: A Historic Review for the Period 2009-2017
TABLE 195: Israeli Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 196: Israeli Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
TABLE 197: Bladder Cancer Therapeutics Market in Israel in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
TABLE 198: Israeli Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
SAUDI ARABIA
TABLE 199: Saudi Arabian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025
TABLE 200: Bladder Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Thousand by Type: 2009-2017
TABLE 201: Saudi Arabian Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 202: Saudi Arabian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
TABLE 203: Bladder Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Thousand by Treatment: 2009-2017
TABLE 204: Saudi Arabian Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
TABLE 205: Bladder Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
TABLE 206: United Arab Emirates Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
TABLE 207: Bladder Cancer Therapeutics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
TABLE 208: Bladder Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 209: United Arab Emirates Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 210: Bladder Cancer Therapeutics Market Share Distribution in United Arab Emirates by Treatment: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
TABLE 211: Bladder Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
TABLE 212: Rest of Middle East Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
TABLE 213: Rest of Middle East Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 214: Bladder Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 215: Rest of Middle East Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 216: Rest of Middle East Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
AFRICA
TABLE 217: African Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025
TABLE 218: Bladder Cancer Therapeutics Market in Africa by Type: A Historic Review in US$ Thousand for 2009-2017
TABLE 219: African Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
TABLE 220: African Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
TABLE 221: Bladder Cancer Therapeutics Market in Africa by Treatment: A Historic Review in US$ Thousand for 2009-2017
TABLE 222: African Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
IV. COMPETITION
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB COMPANY
CELGENE CORPORATION
ELI LILLY AND COMPANY
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
NOVARTIS INTERNATIONAL AG
PFIZER
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook